Risk Management


<< Back
Share
 Print

Giant Cell Arteritis: Delayed diagnosis and treatment

August 17, 2022

Dear OMIC Insureds:

OMIC is pleased to announce the release of our newest Digest:

Giant Cell Arteritis: Delayed diagnosis and treatment

  • Highlights recent claims data, explores new case studies, and offers risk management recommendations
  • Gives you links to practical GCA risk management tools:
  • Updated GCA Checklist
  • New GCA Patient Information Sheet with Consent to/Refusal of Treatment
  • Includes news from OMIC’s Chair, Dan Briceland, MD
  • Provides updated information about liability and coverage issues related to patient falls

 

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com. Or call us at 1-800-562-6642, enter 4 for Risk Management.

Sincerely,

Jane Mock, CPHRM
OMIC Risk Manager

______________________________________________

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684